Absence of the Tks4 Scaffold Protein Induces Epithelial-Mesenchymal Transition-Like Changes in Human Colon Cancer Cells
Overview
Biophysics
Cell Biology
Molecular Biology
Authors
Affiliations
Epithelial to mesenchymal transition (EMT) is a multipurpose process involved in wound healing, development, and certain pathological processes, such as metastasis formation. The Tks4 scaffold protein has been implicated in cancer progression; however, its role in oncogenesis is not well defined. In this study, the function of Tks4 was investigated in HCT116 colon cancer cells by knocking the protein out using the CRISPR/Cas9 system. Surprisingly, the absence of Tks4 induced significant changes in cell morphology, motility, adhesion and expression, and localization of E-cadherin, which are all considered as hallmarks of EMT. In agreement with these findings, the marked appearance of fibronectin, a marker of the mesenchymal phenotype, was also observed in Tks4-KO cells. Analysis of the expression of well-known EMT transcription factors revealed that Snail2 was strongly overexpressed in cells lacking Tks4. Tks4-KO cells showed increased motility and decreased cell-cell attachment. Collagen matrix invasion assays demonstrated the abundance of invasive solitary cells. Finally, the reintroduction of Tks4 protein in the Tks4-KO cells restored the expression levels of relevant key transcription factors, suggesting that the Tks4 scaffold protein has a specific and novel role in EMT regulation and cancer progression.
Predictive value analysis of the interaction network of Tks4 scaffold protein in colon cancer.
Tilajka A, Kurilla A, Laszlo L, Lovrics A, Novak J, Takacs T Front Mol Biosci. 2024; 11:1414805.
PMID: 39234565 PMC: 11371697. DOI: 10.3389/fmolb.2024.1414805.
Laszlo L, Kurilla A, Tilajka A, Pancsa R, Takacs T, Novak J Mol Biol Cell. 2024; 35(8):ar111.
PMID: 38985526 PMC: 11321040. DOI: 10.1091/mbc.E24-03-0103.
Jacksi M, Schad E, Tantos A Biomolecules. 2024; 14(4).
PMID: 38672463 PMC: 11047920. DOI: 10.3390/biom14040445.
Kurilla A, Laszlo L, Takacs T, Tilajka A, Lukacs L, Novak J Int J Mol Sci. 2023; 24(20).
PMID: 37894817 PMC: 10606890. DOI: 10.3390/ijms242015136.
Meng H, Nan M, Li Y, Ding Y, Yin Y, Zhang M Front Endocrinol (Lausanne). 2023; 14:1148412.
PMID: 37020597 PMC: 10067930. DOI: 10.3389/fendo.2023.1148412.